AYTU BIOPHARMA, INC (AYTU) has 8 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: July 30, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 30, 2026 filed July 28, 2026 | Disbrow Joshua R. Chief Executive Officer | $0 | 30,000 | +14% | No | |
|
|
||||||
| July 30, 2026 filed July 28, 2026 | PYSZCZYMUKA GREG Chief Commercial Officer | $0 | 20,000 | +55% | No | |
|
|
||||||
| July 30, 2026 filed July 28, 2026 | Disbrow Jarrett Chief Business Officer | $0 | 15,000 | +24% | No | |
|
|
||||||
| July 30, 2026 filed July 28, 2026 | Selhorn Ryan J Chief Financial Officer | $0 | 25,000 | +50% | No | |
|
|
||||||
| July 30, 2026 filed July 28, 2026 | JAIN ABHINAV Director | $0 | 10,000 | +51% | No | |
|
|
||||||
Showing the 5 most recent of 8 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free